RURean Hayrievna Useinova

Rean Hayrievna Useinova

*This is an algorithmically generated author record based on publicly available information.

Rean Hayrievna Useinova has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lipopolysaccharide-binding systems in the pathogenesis of vascular complications in patients with type 1 diabetes mellitus

    by I. A. Yatskov, V. A. Beloglazov, E. S. Ageeva, R. Kh. Useinova, I. N. Repinskaya, Yu. V. Usachenko

    Rationale. Disturbance of glycemia in type 1 diabetes mellitus (DM1) leads to the development of oxidative stress and damage to the barrier organs for lipopolysaccharide (LPS), which is accompanied by its increased translocation into the systemic bloodstream, inducing vascular damage. The aim. Determination of the influence of the level of major lipopolysaccharidebinding systems on the risk of macro- and microvascular complications of DM1. Materials and methods. The study included 92 patients with a verified diagnosis of type 1 diabetes mellitus. Patients underwent examination of biomaterial (blood plasma) by enzyme-linked immunosorbent assay (ELISA) to determine the level of lipopolysaccharide-binding protein (LBP), bactericidal permeability-increasing protein (BPI) and sCD14, as well as a marker of systemic inflammation – CRP. ROC-analysis with ROC-curve construction was used to assess the quality of the prognostic model efficiency, as well as to find the optimal point (cut-off point) of the threshold value of the level of the investigated markers. Results. ROC-analysis revealed statistically significant patterns of relationship between peripheral blood LBP level and risk of arterial hypertension (AH) in patients with DM1 (p = 0.014), as well as relationship between peripheral blood LBP and sCD14 level and risk of diabetic nephropathy (DN) in patients with DM1 (p = 0.042 and p = 0.048). Conclusion. We have revealed a statistically significant influence of LBP and sCD14 concentrations on the development of vascular lesions in DM1, with a decrease in the level of the main LPS-binding systems accompanied by an increased risk of AH and DN. Lipopolysaccharide of Gram-negative flora plays an important role in the development of complications of DM1, which is largely due to the peculiarities of the response to LPS under conditions of hyperglycemia and dysfunction of the normal response to LPS, accompanied by protective reactions and subsequent clearance of LPS.

  • Arterial hypertension in young patients with type 1 diabetes mellitus. Dysbiosis and increased paracellular intestinal permeability as potential links of pathogenesis

    by R. Kh. Useinova, V. A. Beloglazov, I. N. Repinskaya, I. A. Yatskov

    The incidence of type 1 diabetes is increasing worldwide, especially among young patients. This trend is very unfavorable, since the risk of death of diabetic patients from cardiovascular and other concomitant diseases is five times higher than that of patients without a history of type 1 diabetes. The main causes of premature mortality are micro- and macrovascular complications, aggravated by concomitant diseases, one of which is arterial hypertension. The risk of complications such as acute cerebral circulatory disorders, myocardial infarction, limb amputation, heart failure and sudden cardiac death increases with increasing duration and severity of hypertension, especially with its uncontrolled course. Patients with type 1 diabetes who are under inpatient or outpatient supervision and treatment, for the most part, do not control blood pressure, or are guided by data from home/office blood pressure measurements. In our opinion, it is worth paying special attention to screening diagnostics, early detection, as well as profiles of increased blood pressure in patients with type 1 diabetes, as this will allow us to consider the possibility of initiating antihypertensive treatment or optimizing therapeutic approaches to the management of this group of patients, and is also key to reducing the risk of adverse outcomes of this disease.

  • Open Access

    Imbalance of endotoxin-binding systems in patients with type 1 diabetes

    by I. A. Yatskov, V. A. Beloglazov, E. S. Ageeva, I. N. Repinskaya, R. Kh. Useinova, Yu. S. Saenko

    Rationale. The number of patients with type 1 diabetes mellitus (DM1) in the Russian Federation is 277.1 thousand people, and this number continues to grow. Disturbance of glycemia leads to the development of oxidative stress and damage to the walls of the vascular channel, increasing cardiovascular risk in patients with DM1. Endothelial and enterocyte damage leads to translocation of bacterial components, particularly lipopolysaccharide (LPS), into the systemic bloodstream and the development of a state of “metabolic endotoxemia” that supports inflammation. The aim of the study. To evaluate the levels of all major LPS-binding systems and C-reactive protein (CRP) levels in patients with DM1. Materials and methods. The study included 92 patients with a verified diagnosis of type 1 diabetes mellitus. A control group of 42 practically healthy respondents, who were comparable to the DM1 group in terms of age and gender, was also formed. Patients in both groups were examined for biomaterial (blood plasma) by enzyme-linked immunosorbent assay (ELISA) to determine the level of lipopolysaccharide-binding protein (LBP), bactericidal permeability-increasing protein (BPI) and sCD14, as well as a marker of systemic inflammation – CRP. Results. In patients with DM1, there was a statistically significant increase in the levels of LBP and sCD14 compared to the corresponding indicators of the control group (p < 0.001). BPI levels were significantly lower in the group of patients with DM1 than in the control group (p < 0.001). The DM1 group had a statistically higher CRP level of 0.81 (0.43–2.07) compared to the control group (p < 0.001). Conclusion. Our results indicate the dysregulation and imbalance of LPS-binding systems in patients with DM1. We also found a significantly higher level of SRB in patients with DM1, which confirms the presence of low-intensity inflammation in these patients.

  • Open Access

    Low-grade systemic inflammation in patients with long COVID: The role of imbalance of endotoxin-releasing systems and vasoconstrictor markers

    by V. A. Beloglazov, L. Sh. Dudchenko, R. Kh. Useinova, I. A. Yatskov, E. A. Solovyova, G. N. Andreeva

    Background. Currently, the pathophysiological mechanisms of acute damage to organs and systems caused by coronavirus infection have been studied quite fully, but the mechanisms underlying the clinical manifestations of long COVID have not yet been accurately described. The mechanisms of persistence of a number of symptoms in patients who have had COVID-19 and the role of systemic inflammation and endotoxemia markers in it remain a understudied aspect and a promising direction for further studying.The aim of the study. To assess the markers of systemic inflammation, endotoxin-releasing systems, intestinal permeability and endothelial dysfunction in patients with long COVID at the stage of health resort treatment.Methods. The study included 32 patients who had recovered from coronavirus infection and were undergoing health resort treatment in the pulmonology department of the I.M. Sechenov Academic Research Institute for Physical Therapy, Medical Climatology and Rehabilitation. We also selected a control group (n = 20). All patients underwent peripheral blood analysis to detect the levels of markers of systemic inflammation, endotoxin-releasing systems, intestinal permeability, endothelial dysfunction and vasoconstrictor agents: C-reactive protein (CRP), lipopolysaccharide-binding protein (LPB), tissue-type plasminogen activator (tPA), zonulin, bactericidal/ permeability-increasing protein (BPI), vasopressors of angiotensin 2 and endothelin (EDN1).Results. Patients who had recovered from coronavirus infection had a statistically significant increase in the levels of CRP (3.4 [2.56; 4.0] mg/l), LBP (18.46 [14.0; 25.5] ng/ml), tPA (0.07 [0.02; 0.32] ng/ml), angiotensin 2 (133.3 [63.0; 503.7] pg/ml) and a decrease in the level of BPI (1576 [276; 3588] pg/ml) (p < 0.05).Conclusion. A statistically significant increase in markers of systemic inflammation, endotoxinemia, and vasoconstrictor agents in patients with long COVID indicates an imbalance in endotoxin-binding and endotoxin-releasing systems in patients who have had coronavirus infection. Further study of the described markers is necessary to improve approaches to long-term personalized therapy for this category of patients.


  • Open Access

    Low-grade inflammation in the post-COVID period as a strategic goal of treatment and rehabilitation

    by V. A. Beloglazov, I. A. Yatskov, R. Kh. Useinova

    As of the beginning of 2023, there are more than 660 million convalescents of a new coronavirus infection in the world, however, even despite successful treatment of the acute period of the disease, such patients have a high risk of developing long-term complications in the post-COVID period, primarily cardiovascular events. One factor that seriously increases the risk of these complications is the state of lowgrade systemic inflammation (LGSI). LGSI is not a clinical diagnosis, it is characterized by a level of C-reactive protein in peripheral blood in the range of 3–10 mg/l and is most often detected during routine examination of patients, who in most cases have no clinical symptoms. In this regard, the condition of LGSI most often remains unnoticed and unreasonably ignored, despite quite extensive literature data on the effect of LGSI on the pathogenesis of many cardiovascular diseases. The development of drug therapy for LGSI is complicated by the multifactorial etiology of this condition. The causes of LGSI can be both genetic factors, which are practically impossible to correct, and conditions that are amenable to drug and non-drug treatment, such as, for example, increased intestinal permeability to pro-inflammatory agents, including lipopolysaccharide of gram-negative flora, the presence of a chronic untreated infection site and endocrine pathology (obesity and type 2 diabetes). This review presents the main information to date on the state of LGSI in patients who had a new coronavirus infection, including the results of our own observations of patients who have undergone a course of rehabilitation measures, as well as the most significant, in our opinion, factors predisposing to the development of LGSI in such patients.


  • Open Access

    Delaminating Intramyocardial Hematoma in Patients with Heart Failure with Reduced Ejection Fraction: а Series of Clinical Cases

    by A. F. Safarova, R. Kh. Useinova, Zh. D. Kobalava, L. V. Karapetyan

    Delaminating intramyocardial hematoma (DIMH) is a rare and potentially life-threatening complication of acute myocardial infarction. Currently, only isolated reports of cases of myocardial dissection have been published, and until recently, the diagnosis of DIMH was carried out during autopsy or surgery. The article describes echocardiographic criteria and discusses some aspects of the therapy of this pathology. The description of clinical cases of noninvasive diagnosis of DIMH in men aged 60 and 62 years hospitalized with the clinic of decompensation of chronic heart failure is given. This complication in the presented patients was diagnosed using transthoracic echocardiography, thanks to which it was possible to identify the dissection of the myocardium, as well as to trace the dynamics of the organization of an intramyocardial hematoma into a parietal thrombus. Various approaches to patient management are demonstrated: conservative tactics allowed to successfully stabilize the course of chronic heart failure in the first patient, while the condition of the other required the transplantation of a donor heart a few months after discharge from the hospital.

  • Open Access

    Modern view on the etiopathogenesis of heart rhythm disorders and methods of their correction in pregnant women

    by R. Kh. Useinova, A. N. Sulima, A. N. Rybalka, D. A. Beglitse, Z. S. Rumyantseva, P. N. Baskakov, M. A. Dizha, E. M. Dolya

    Introduction. Issues of etiopathogenesis for various cardiovascular disorders in the structure of extragenital diseases during pregnancy pose an urgent problem and represent a global topic for further scientific research. Due to the high frequency of heart rhythm disorders in pregnant women, it is necessary to improve their management.Aim: to analyze data from the current literature on the etiopathogenesis of arrhythmias during gestation and effective methods of their correction.Materials and Methods. Literature sources of electronic databases PubMed/MEDLINE, Medscape, Google Scholar, Embase, Ovid Healthstar, Cochrane, eLibrary, CyberLeninka and scientific articles in peer-reviewed open access journals published across the last 25 years, including basic research on this pathology have been analyzed. The search in databases used keywords and their combinations in Russian and English: "arrhythmias", "arrhythmias in pregnancy", "pathogenesis of gestational arrhythmias".Results. There have been analyzed major aspects of the etiology and pathogenesis of gestational arrhythmias as well as potential causes for developing first-time rhythm disorders in pregnant women and features of the gestational period as a predictor of emerging arrhythmias in patients with pre-existing pathology of the cardiovascular system are determined. The article describes the most common rhythm disorders and acceptable ways to correct them, taking into account the latest recommendations and research in this area.Conclusion. The authors concluded that the etiopathogenesis of rhythm disorders during pregnancy and their treatment methods require further examination.


  • Open Access

    Expression and polymorphism of lTLR4 receptors in pathogenesis of chronic obstructive pulmonary disease: a modern view

    by V. A. Beloglazov, I. A. Yatskov, Rean Hayrievna Useinova, А. А. Яцков

    Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by irreversible or partially reversible obstruction of the bronchial tree. Currently, there are many proven links in the COPD etiopathogenesis, among which a pivotal role is assigned to the value of the hyperergic inflammatory reaction in response to inhalation of various harmful substances (tobacco smoke, industrial pollutants, etc.). The number of macrophages, neutrophils, lymphocytes increases in the lungs of COPD patients, and these cells secrete a fairly wide range of inflammatory mediators. Bacterial colonization of the airways is one of the key features in COPD pathogenesis leading to persistent or chronic stimulation of immune cells through Tolllike receptors (TLR), which perceive the pathogen-associated molecular patterns (PAMPs).This article provides a review of literature concerning modern concepts of the role of Toll-like receptors expression and polymorphism, in particular, TLR4, in pathogenesis of COPD. TLR4 is a member of the Tolllike receptor family that plays a fundamental role in pathogen identification and innate immune activation. By recognizing the pathogen-associated molecular patterns (PAMPs) expressed on infectious agents, TLRs mediate the production of cytokines necessary for the development of effective immunity. Different TLRs exhibit distinct expression patterns. This receptor is most abundantly expressed in placenta and in the myelomonocytic leukocyte subpopulations. E.g., Di Stefano A. et al. (2017), determined immunohistochemically the expression levels of TLR2, TLR4, TLR9, NOD1, NOD2, CD14, Toll-interleukin-1-receptor domain containing adapter protein (TIRAP) and interleukin-1-receptor-associated phosphokinases (IRAK1 and IRAK4) in bronchial mucosa of patients with stable COPD of varying severity. It was found that TLR4 expression of the bronchial epithelium positively correlated with degree of obstruction and CD4+ and CD8+T cell contents. Stimulation of TLR4 increases cytokine production, which may be a relevant mechanism by which bacteria cause excessive inflammation in COPD patients. The degree of TLR4 involvement into COPD pathogenesis requires more detailed study in future, in order to determine the main mechanisms for emerging inflammatory response in the airways. This review article is part of a research grant project to study pro-inflammatory response to endotoxin of Gram-negative flora in COPD pathogenesis (State registration number – АААА-А19-119122390040-2).